Bolton Lab

Disorders of Neural Circuit Function

Play Video

McLean Bolton

Research Group Leader

Bio

Dr. M. McLean Bolton started her research program at the Max Planck Florida Institute for Neuroscience as an independent Research Group Leader focusing on disorders of neural circuitry in January of 2011. Prior to this appointment, she was a Research Assistant Professor in the Department of Pediatrics, Division of Neurology at Duke University Medical Center (2008-2010).

Continue reading


Bolton’s early postgraduate career was in ion channel drug discovery and developing high content screening platforms for neurological disorders (2000-2008). Before returning to basic research in 2008, she worked as a Research Scholar for the Duke Drug Discovery Center, a Senior Scientist at Icagen, Inc., a Scientist II at Amphora Discovery Corporation, and an Investigator at Cogent Neuroscience, Inc.

She received her Ph.D. in Neurobiology at Duke University in 2000 for her work on the regulation of excitatory and inhibitory synaptic transmission in hippocampal cultures by brain-derived neurotrophic factor. Her thesis work was supported by an individual National Research Service Award.

 

Research

Research Topic

The goal of Bolton’s research is to understand how neural circuits are altered in neuropsychiatric disorders, such as autism and schizophrenia. These complex behavioral disorders are caused by a combination of genetic and environmental factors. Most cases likely result from a combination of mutations in many genes, each with small effects. However, rare mutations in candidate genes with large effects, either de novo or inherited, are major contributors to the etiology of these disorders in a subset of cases.

Continue reading

Studying the impact of these rare mutations on brain function may identify points of intervention to correct the circuit imbalances in these neuropsychiatric disorders. They combine optogenetics, patch-clamp electrophysiology, 2-photon imaging, and behavioral studies to map local circuit and long-range synaptic connectivity in mouse models of these disorders and to relate these circuit changes to behavioral abnormalities and neuronal activity patterns during behavior.

Current Projects

Project 1 – Searching for common circuitry endophenotypes among genetic models of autism

A revolution in psychiatric genetics has led to a growing list of candidate genes conveying susceptibility to autism spectrum disorders (ASD). The implicated molecules have diverse functions, ranging from protein synthesis control to synaptic adhesion, leading to the hypothesis that these disparate genetic changes converge onto a common neuronal circuit pathology in ASD rather than a common molecular pathology. We have developed methods for circuit mapping that enable measurements of functional synaptic connectivity with single-neuron resolution. By expanding a two-photon beam in the imaging plane using the temporal focusing method, and restricting channelrhodopsin to the soma and proximal dendrites, we are able to reliably evoke action potentials in individual neurons, verify spike generation with GCaMP6s, and determine the presence or absence of synaptic connections with patch-clamp electrophysiological recording. We are searching for common circuitry endophenotypes among multiple animal models of ASD using this method.

Project 2 – The role of cannabinoids in susceptibility for developing schizophrenia

Endocannabinoids are powerful neuromodulators that regulate learning, motivation, decision making, and emotion. Whereas endocannabinoids are released with spatial and temporal precision in response to environmental stimuli to control learning and emotional responses, the THC in marijuana hijacks the cannabinoid system. Given that there is evidence that the endocannabinoid system may be off balance in anxiety disorders, PTSD and schizophrenia, it is important to understand how marijuana affects the development and function of brain circuits involved in emotional regulation in models of genetic and environmental susceptibility to these disorders. We combine a constitutive or cell class-specific knock out model of a candidate schizophrenia susceptibility gene with adolescent exposure to cannabinoids and determine how synaptic connectivity, behavior and neural activity during behavior is altered.

Project 3 – Understanding the contribution of amygdala circuitry defects in Autism and Schizophrenia

The amygdala is a critical plasticity site for the acquisition of emotionally charged memories and plays a significant role in emotional behavior. Alterations in amygdala function are consistent with anxiety and social motivation deficits in both disorders, and paranoid ideations in schizophrenia. The lateral amygdala (LA) is the primary site of synaptic plasticity in fear learning. It receives sensory information from both the thalamus and cortex such that it can associate intrinsically aversive stimuli with neutral stimuli that are paired with it. The basal amygdala (BA) is a central integrator of emotional context. The BA is driven by the LA and regulated by inputs from the medial prefrontal cortex (mPFC) to provide executive control over fear behavior. Amygdala processing is regulated by several classes of inhibitory neurons either local circuit interneurons or those located in specialized clusters like the intercalated cells surrounding the basolateral amygdala (BLA). From the BLA information travels to the central amygdala which is the major output nuclei for fear expression. Understanding how individual elements within the amygdala processing stream are altered in models of autism and schizophrenia is the goal of this project.

Open Positions

Loading…

Lab

Lab Members

Recent Papers

Publications

PTEN in somatostatin neurons regulates fear and anxiety and is required for inhibitory synaptic connectivity within central amygdala

Holford, T. W., Letourneau, K. N., Von-Walter, C., Moncaleano, D., Loomis, C. L., & Bolton, M. M. (2025). PTEN in somatostatin neurons regulates fear and anxiety and is required for inhibitory synaptic connectivity within central amygdala. Frontiers in Cellular Neuroscience, 19.  

Screening Morphological Characteristics of Large Populations of Synaptic Vesicle Clouds and Active Zones from 3D EM Data

Thomas, C. I., Anderson, J. R., Bolton, M., & Kamasawa, N. (2023). Screening Morphological Characteristics of Large Populations of Synaptic Vesicle Clouds and Active Zones from 3D EM Data. Microscopy and Microanalysis: The Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada, 29(29 Suppl 1), 1084–1085.  

Amygdala Intercalated Cells: Gate Keepers and Conveyors of Internal State to the Circuits of Emotion.

Asede, D., Doddapaneni, D., & Bolton, M. M. (2022). Amygdala Intercalated Cells: Gate Keepers and Conveyors of Internal State to the Circuits of Emotion. Journal of Neuroscience, 42(49), 9098–9109.
 

Neuromodulatory control of inhibitory network arborization in the developing postnatal neocortex.

Steinecke, A., Bolton, M. M., & Taniguchi, H. (2022). Neuromodulatory control of inhibitory network arborization in the developing postnatal neocortex. Science Advances, 8(10), eabe7192.  

Deletion of ErbB4 Disrupts Synaptic Transmission and Long-Term Potentiation of Thalamic Input to Amygdalar Medial Paracapsular Intercalated Cells

Asede, D., Okoh, J., Ali, S., Doddapaneni, D., Bolton, M.M. (2021). Deletion of ErbB4 Disrupts Synaptic Transmission and Long-Term Potentiation of Thalamic Input to Amygdalar Medial Paracapsular Intercalated Cells. Front Synaptic Neurosci. 13, 697110. 

Apical intercalated cell cluster: A distinct sensory regulator in the amygdala

Asede, D.*, Doddapaneni, D.*, Chavez, A., Okoh, J., Ali, S., Von-Walter, C., Bolton, M.M. (2021) Apical intercalated cell cluster: A distinct sensory regulator in the amygdala. Cell Reports 35, 7, 109151. 

All Labs

Bidaye Lab

Dr. Bidaye started his Research Group Leader position at the Max Planck Florida Institute for Neuroscience in April 2021, leading the Neuronal Control of Locomotion group. His research focuses on understanding how fast and precise locomotor decisions are executed at the level of genetically defined neural circuits.  

Continue Reading..  

Bolton Lab

Dr. M. McLean Bolton started her research program at the Max Planck Florida Institute for Neuroscience as an independent Research Group Leader focusing on disorders of neural circuitry in January of 2011. Prior to this appointment, she was a Research Assistant Professor in the Department of Pediatrics, Division of Neurology at Duke University Medical Center (2008-2010).  

Continue Reading..  

Fitzpatrick Lab

Dr. Fitzpatrick was named Chief Executive Officer and Scientific Director of the Max Planck Florida Institute on January 3, 2011. Prior to his arrival in Jupiter, Fitzpatrick was the James B. Duke Professor of Neurobiology at the Duke University School of Medicine, Durham, NC, and Director of the Duke Institute for Brain Sciences. His scientific contributions have earned him international recognition as a leader in systems neuroscience, with a focus on the functional organization and development of neural circuits in the cerebral cortex — the largest and most complex area of the brain, whose functions include sensory perception, motor control, and cognition.  

Continue Reading..  

Inagaki Lab

Dr. Inagaki started his Research Group Leader position at the Max Planck Florida Institute for Neuroscience (MPFI) in September 2019 leading the Neural Dynamics and Cognitive Functions research group. His current research focus is to understand cellular and network mechanisms underlying cognitive functions, such as purposeful movement initiation and time perception, in mice.  

Continue Reading..  

Rangaraju Lab

Dr. Vidhya Rangaraju started her Research Group Leader position at the Max Planck Florida Institute for Neuroscience in January 2020. The overarching goal of the Rangaraju group is to investigate the energy use and supply of biological processes in neurons.  

Continue Reading..  

Stern Lab

Dr. Sarah Stern started her position as Research Group Leader at the Max Planck Florida Institute for Neuroscience in January 2021, leading the Integrative Neural Circuits and Behavior research group. The laboratory’s current research focuses on understanding, from genes to circuits, how learning integrates with internal drives to produce flexible behavioral outcomes  

Continue Reading..  

Tian Lab

Dr. Lin Tian started as Scientific Director of the Max Planck Florida Institute in October 2023. Before this, she was the Professor and Vice Chair in the Department of Biochemistry and Molecular Medicine at the University of California Davis School of Medicine. Her scientific contributions have earned her international recognition as a leader in neuroengineering, with a focus on generating new molecular tools to understand and repair the brain. In addition, Dr. Tian actively disseminates her methodologies to the wider scientific community and is an advocate for open science. She has received multiple awards and honors, including an NIH New Innovator Award, W.M. Keck Foundation Award, Human Frontier Science Program Young Investigator Award, and has been named a Rita Allen Scholar and Hartwell Scholar.  

Continue Reading..  

Wang Lab

Dr. Wang joined the Max Planck Florida Institute for Neuroscience (MPFI) in February 2018 leading the Neuronal Mechanisms of Episodic Memory research group.  

Continue Reading..  

Yasuda Lab

Dr. Yasuda started as Scientific Director of the Max Planck Florida Institute in January 2012. Before this, he was an assistant professor in the Neurobiology department at Duke University Medical Center in Durham, NC. Yasuda has received a number of awards for his research accomplishments, including the Career Award at the Scientific Interface from the Burroughs Wellcome Fund, the Alfred P. Sloan Fellowship, the New Investigator Award from the Alzheimer’s Association, the Research Award for Innovative Neuroscience from the Society for Neuroscience and the National Institute of Health’s (NIH) Pioneer award.  

Continue Reading..